Trajectory of NAFLD characteristics after Roux-en-Y gastric bypass: a five-year historical cohort study
Authors:
- Fernanda KreveFKFernanda Kreve
- Guilherme Hoverter CallejasGCGuilherme Hoverter Callejas
- Laísa Simakawa JimenezLJLaísa Simakawa Jimenez
- Rodolfo Araújo MarquesRMRodolfo Araújo Marques
- Felipe David Mendonça ChaimFCFelipe David Mendonça Chaim
- Murillo Pimentel UtriniMUMurillo Pimentel Utrini
- Martinho Antonio GesticMGMartinho Antonio Gestic
- Almino Cardoso RamosARAlmino Cardoso Ramos
- Elinton Adami ChaimECElinton Adami Chaim
- Everton CazzoECEverton Cazzo
Open Access
- 12 September 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Sao Paulo Medical Journal
- Vol. 140 (6) , 739-746
Abstract
BACKGROUND: The long-term effects of bariatric surgery on the course of non-alcoholic fatty hepatopa-thy (NAFLD) are not fully understood.OBJECTIVE: To analyze the evolution of NAFLD characteristics through noninvasive markers after Roux-en-Y gastric bypass (RYGB) over a five-year period.DESIGN AND SETTING: Historical cohort study; tertiary-level university hospital.METHODS: The evolution of NAFLD-related characteristics was evaluated among 49 individuals who un-derwent RYGB, with a five-year follow-up. Steatosis was evaluated through the hepatic steatosis index (HSI), steatohepatitis through the clinical score for non-alcoholic steatohepatitis (C-NASH) and fibrosis through the NAFLD fibrosis score (NFS).RESULTS: 91.8% of the individuals were female. The mean age was 38.3 +/- 10 years and average body mass index (BMI), 37.4 +/- 2.3 kg/m2. HSI significantly decreased from 47.15 +/- 4.27 to 36.03 +/- 3.72 at 12 months (P < 0.01), without other significant changes up to 60 months. C-NASH significantly decreased from 0.75 +/- 1.25 to 0.29 +/- 0.7 at 12 months (P < 0.01), without other significant changes up to 60 months. NFS de-creased from 1.14 +/- 1.23 to 0.27 +/- 0.99 at 12 months (P < 0.01), and then followed a slightly ascending course, with a marked increase by 60 months (0.82 +/- 0.89), but still lower than at baseline (P < 0.05). HSI variation strongly correlated with the five-year percentage total weight loss (R = 0.8; P < 0.0001).CONCLUSION: RYGB led to significant improvement of steatosis, steatohepatitis and fibrosis after five years. Fibrosis was the most refractory abnormality, with a slightly ascending trend after two years. Steato-sis improvement directly correlated with weight loss.Keywords
This publication has 30 references indexed in Scilit:
- Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive reviewSao Paulo Medical Journal, 2017
- Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesitySurgery for Obesity and Related Diseases, 2017
- 10-Year Outcomes After Roux-en-Y Gastric BypassAnnals of Surgery, 2016
- Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and HistologyObesity Surgery, 2015
- Effect of Roux-en-y Gastric Bypass on Nonalcoholic Fatty Liver Disease Evaluated Through NAFLD Fibrosis Score: a Prospective StudyObesity Surgery, 2014
- Nonalcoholic fatty liver disease in Brazil. Clinical and histological profileAnnals of Hepatology, 2011
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver diseaseDigestive and Liver Disease, 2010
- Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced DiseaseGastroenterology, 2009
- The NAFLD fibrosis scoreHepatology, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005